Differences Between Post-Authorization Adverse Drug Reactions of Biopharmaceuticals and Small Molecules-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differences Between Post-Authorization Adverse Drug Reactions of Biopharmaceuticals and Small Molecules

Published:2013-02-12 Issue:2 Volume:27 Page:167-174
ISSN:1173-8804
Container-title:BioDrugs
language:en
Short-container-title:BioDrugs

Author:

Ebbers Hans C.,Al-Temimi Esraa,Moors Ellen H. M.,Mantel-Teeuwisse Aukje K.,Schellekens Huub,Leufkens Hubert G. M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s40259-013-0012-y.pdf

Reference26 articles.

1. Clark JB. Mechanisms of adverse drug reactions to biologics. In: Uetrecht J, editor. Adverse drug reactions. Berlin: Springer; 2010. p. 453–74.

2. Baumann A. Early development of therapeutic biologics: pharmacokinetics. Curr Drug Metab. 2006;7(7):15–21.

3. Giezen TJ, Mantel-Teeuwisse AK, Leufkens HG. Pharmacovigilance of biopharmaceuticals: challenges remain. Drug Saf. 2009;32(10):811–7.

4. Giezen TJ, Mantel-Teeuwisse AK, Meyboom RH, Straus SM, Leufkens HG, Egberts TC. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase. Drug Saf. 2010;33(10):865–78.

5. Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Schellekens H, Leufkens HG, Egberts AC. Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA. 2008;300(16):1887–96.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Photosensitizer Temoporfin ( m THPC ) – Chemical, Pre‐clinical and Clinical Developments in the Last Decade ^† ^‡;Photochemistry and Photobiology;2022-11-03

2. Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF‐α Inhibitors;Clinical Pharmacology & Therapeutics;2020-12-28

3. Pharmacovigilance;Pharmacoepidemiology and Pharmacovigilance;2019

4. THE EVALUATION OF IMMUNOGENIC POTENTIAL OF VARIOUS MEDICATIONS OF INSULIN;Medical Journal of the Russian Federation;2018-02-15

5. Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis;Scientific Reports;2017-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3